Price range: £172.50 through £603.75
IGF-1 LR3 is an IGF-1 LR3 peptide engineered as a long-acting analogue of insulin-like growth factor-1. Researchers use this recombinant peptide to study cell-growth regulation, IGF receptor activation, and metabolic signaling in controlled laboratory environments. Because IGF-1 LR3 includes a modified amino-acid sequence that reduces binding to IGF-binding proteins, it offers extended receptor availability compared with native IGF-1.
Scientists value the IGF-1 LR3 peptide for its ability to stimulate cellular proliferation, differentiation, and survival pathways in vitro. It supports studies focused on PI3K/AKT signaling, protein synthesis regulation, and anabolic cellular responses under defined conditions. In addition, the structural modifications in IGF-1 LR3 allow researchers to examine potency and duration differences between the analogue and the endogenous hormone.
Laboratories often choose the IGF-1 LR3 peptide for:
Analysing IGF-1 receptor signaling and downstream pathways
Studying growth-factor-driven cellular proliferation
Comparing receptor affinity between modified and native IGF-1
Exploring metabolic and anabolic responses in isolated models
Because IGF-1 LR3 provides predictable signaling kinetics and high bioactive stability, it supports precise mechanistic work and reproducible outcomes across replicate experiments. This makes the peptide suitable for rigorous cell-biology, metabolic-pathway, and molecular-regulation research.
Our IGF-1 LR3 peptide is supplied as a high-purity laboratory reagent intended only for qualified scientific professionals. It is not approved for clinical, diagnostic, therapeutic, or veterinary use. All research involving IGF-1 LR3 must comply with institutional safety policies and regulatory requirements for experimental bioregulatory compounds.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
